Weimin Ding
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Journal: bioRxiv : the preprint server for biology
Published: October 31, 2023
Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Journal: Research square
Published: October 27, 2023
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma.
Journal: Nature communications
Published: December 11, 2022
UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer.
Journal: Bioengineered
Published: May 09, 2022
Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration.
Journal: Frontiers in oncology
Published: March 05, 2021
High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.
Journal: Cancer medicine
Published: February 19, 2021
Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma.
Journal: Frontiers in immunology
Published: November 28, 2020
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer.
Journal: Frontiers in cell and developmental biology
Published: September 22, 2020
CARD11 alteration as a candidate biomarker of skin cutaneous melanoma treated with immune checkpoint blockade.
Journal: American journal of translational research
Published: July 26, 2020
DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress.
Journal: The Journal of cell biology
Published: February 01, 2017
Serum microRNA-218 is a potential biomarker for esophageal cancer.
Journal: Cancer biomarkers : section A of Disease markers
Published: March 28, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026